Seegene Inc

Select Menu

Press Release You can check out news about Seegene from various media

Jun. 29
2021

Seegene unveils "MOBILE STATION," for on-site routine testing at public-use facilities and communities

- Seegene unveils "MOBILE STATION" at the Medlab Middle East 2021 - Mobile laboratory designed for mass testing at schools, airports, or communities, delivering test results within 3h 30min with ...

PR Newswire
May. 24
2021

Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID

Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year’s European Con...

PR Newswire
May. 12
2021

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

- SEEGENE POSTS KRW 193.9 BIL. IN OPERATING PROFIT, UP 388% ON-YEAR - OPERATING PROFIT RATIO AT 55%, DESPITE CONSTANT INVESTMENT IN R&D AND EMPLOYEES Seegene Inc. (KQ 096530), a molecular di...

PR Newswire
May. 11
2021

Seegene’s Germany subsidiary supports the back-to-school initiative with its COVID-19 tests

- SEEGENE BACKS GERMANY IN ITS EFFORT TO RETURN TO NORMALCY - GERMAN SUBSIDIARY TO SUPPLY COVID-19 DIAGNOSTIC TESTS ENOUGH TO TEST 734,000 PUPILS Seegene Inc. (KQ 096530), a leading molecul...

PR Newswire
Apr. 22
2021

Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year

Second public procurement agreement after Italy’s procurement deal worth EUR 89.3 million Seegene Inc. (KQ 096530), a leading biotechnology firm said it began supplying its COVID-19 diagnostic te...

PR Newswire
Apr. 13
2021

Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic

Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month SEOUL, Korea (April 12, 2021) – Seegene Inc. (KQ 096530), a biotechnology company specia...

PR Newswire
Apr. 09
2021

Seegene supports Mexico’s ‘back to school’ campaign with COVID-19 tests and face masks

South Korea’s leading molecular diagnostics firm Seegene Inc. (KQ096530) said Friday it is supporting the Mexican government’s push to return life to pre-pandemic days. During a ceremonial event...

PR Newswire
Mar. 03
2021

Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay

Real-time test differentiates influenza A & B, RSV and COVID-19SEOUL, South Korea (March 1, 2021)— Seegene Inc., (KQ096530), a biotechnology company specializing in molecular diagnostics, has s...

BUSINESS WIRE
Mar. 03
2021

Seegene’s Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants

- Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min - Seegene’s proprietary high multiplex technology enables detection of 10 different targets - S. K...

PR Newswire
Feb. 16
2021

Seegene’s saliva test for COVID-19 is just as effective as NPS test

A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine ...

PR Newswire
Feb. 01
2021

Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants

- SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST - COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS - S. KOREAN FIRM COMMITTED TO WORKING WITH GOVERNMENTS South Korea’s...

PR Newswire
Jan. 21
2021

Seegene to advance business in Latin America in the New Year

South Korea’s leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business in Latin America in the new year with a strong focus on its multiplex assay ...

이데일리 PR Newswire 조선일보 연합뉴스
Jan. 07
2021

Seegene’s COVID-19 test with saliva sample collection feature now available in Europe

South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2...

PR Newswire Korea Biomedical Review
Dec. 17
2020

Seegene donates 20,000 COVID-19 tests to Ecuador

Seegene Inc. (KQ096530), a South Korean biotechnology company specializing in molecular diagnostics says it has donated 20,000 COVID-19 tests (Allplex™ SARS-CoV-2 Assay) to Ecuadorian government to he...

PR Newswire

1 2 3 4 5

Choose your location

Choose your country

Press Release You can check out news about Seegene from various media

Seegene unveils "MOBILE STATION," for on-site routine testing at public-use facilities and communities

Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

Seegene’s Germany subsidiary supports the back-to-school initiative with its COVID-19 tests

Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year

Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic

Seegene supports Mexico’s ‘back to school’ campaign with COVID-19 tests and face masks

Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay

Seegene’s Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants

Seegene’s saliva test for COVID-19 is just as effective as NPS test

Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants

Seegene to advance business in Latin America in the New Year

Seegene’s COVID-19 test with saliva sample collection feature now available in Europe

Seegene donates 20,000 COVID-19 tests to Ecuador